AF
RVMD icon

Amalgamated Financial’s Revolution Medicines RVMD Stock Holding History

Amalgamated Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$192K Buy
+7,522
New +$164K ﹤0.01% 1911

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amalgamated Financial's RVMD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Revolution Medicines (RVMD) in Q1 2022: 7,522 shares worth $192K. The stake represents ﹤0.01% of the portfolio and ranks #1911 among its holdings.

126 funds tracked by Wall St. Rank hold RVMD as of Q1 2022.

  • Amalgamated Financial held 7,522 shares of Revolution Medicines worth $192K as of Q1 2022.
  • Revolution Medicines was a new Amalgamated Financial position in Q1 2022.
  • Revolution Medicines made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1911 holding.
  • 126 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.